Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

Study Design: ARISE is an observational, multicenter, longitudinal study using a retrospective cohort of CLL patients who began acalabrutinib treatment between May 2021 and April 2022. The study will ...

Alex Tordoff is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut. The Oakham ace, 28, grew up just 20 minutes away from Stamford's ...

HBAR tests key support at $0.23 after a 3% pullback Friday, with resistance forming near $0.24. Bullish catalysts emerge as ...